Transcat, Inc. $TRNS Shares Bought by Quantinno Capital Management LP

Quantinno Capital Management LP lifted its holdings in shares of Transcat, Inc. (NASDAQ:TRNS) by 184.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 14,548 shares of the scientific and technical instruments company’s stock after purchasing an additional 9,434 shares during the period. Quantinno Capital Management LP’s holdings in Transcat were worth $1,069,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of TRNS. Wellington Management Group LLP grew its holdings in Transcat by 677.7% during the fourth quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock worth $14,100,000 after acquiring an additional 216,579 shares during the period. First Eagle Investment Management LLC purchased a new position in Transcat in the fourth quarter worth $7,259,000. King Luther Capital Management Corp lifted its holdings in Transcat by 182.3% in the fourth quarter. King Luther Capital Management Corp now owns 103,750 shares of the scientific and technical instruments company’s stock valued at $5,886,000 after acquiring an additional 67,000 shares during the period. Royce & Associates LP lifted its holdings in Transcat by 15.3% in the fourth quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock valued at $22,156,000 after acquiring an additional 51,774 shares during the period. Finally, Renaissance Technologies LLC boosted its position in shares of Transcat by 109.7% during the 4th quarter. Renaissance Technologies LLC now owns 95,200 shares of the scientific and technical instruments company’s stock worth $5,401,000 after purchasing an additional 49,800 shares in the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on TRNS shares. Weiss Ratings raised shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, May 28th. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Northland Securities downgraded shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price objective on the stock. in a report on Wednesday, August 5th. Finally, Wall Street Zen upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $105.50.

Insider Buying and Selling at Transcat

In related news, Director Christopher P. Gillette sold 504 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $94.23, for a total value of $47,491.92. Following the sale, the director directly owned 200 shares in the company, valued at $18,846. The trade was a 71.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Craig D. Cairns acquired 1,050 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was acquired at an average cost of $93.97 per share, for a total transaction of $98,668.50. Following the completion of the purchase, the director owned 1,480 shares in the company, valued at $139,075.60. The trade was a 244.19% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 1.80% of the company’s stock.

Transcat Stock Performance

Shares of TRNS stock opened at $93.70 on Friday. The stock has a fifty day moving average price of $90.05 and a 200 day moving average price of $80.70. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49. The stock has a market cap of $877.03 million, a PE ratio of 253.24 and a beta of 0.68. Transcat, Inc. has a 1 year low of $50.23 and a 1 year high of $100.00.

Transcat (NASDAQ:TRNS) last posted its earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The company had revenue of $92.95 million for the quarter, compared to analyst estimates of $86.55 million. Sell-side analysts forecast that Transcat, Inc. will post 1.74 earnings per share for the current fiscal year.

Transcat Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.